Switch theme
Sign up to access all valuation multiples
Dignitana AB is a medical technology company, that develops, produces, and markets The DigniCap Scalp Cooling System. It is a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy to improve well-being and quality of life. Geographically, it derives a majority of revenue from the USA.
2007
27
LTM Revenue $10.0M
LTM EBITDA $39K
$18.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dignitana has a last 12-month revenue (LTM) of $10.0M and a last 12-month EBITDA of $39K.
In the most recent fiscal year, Dignitana achieved revenue of $9.3M and an EBITDA of -$0.3M.
Dignitana expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dignitana valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $10.0M | XXX | $9.3M | XXX | XXX | XXX |
| Gross Profit | $6.8M | XXX | $6.2M | XXX | XXX | XXX |
| Gross Margin | 69% | XXX | 67% | XXX | XXX | XXX |
| EBITDA | $39K | XXX | -$0.3M | XXX | XXX | XXX |
| EBITDA Margin | 0% | XXX | -4% | XXX | XXX | XXX |
| EBIT | -$1.3M | XXX | -$1.9M | XXX | XXX | XXX |
| EBIT Margin | -13% | XXX | -20% | XXX | XXX | XXX |
| Net Profit | -$1.4M | XXX | -$2.0M | XXX | XXX | XXX |
| Net Margin | -14% | XXX | -21% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $0.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Dignitana's stock price is SEK 2 (or $0).
Dignitana has current market cap of SEK 176M (or $18.2M), and EV of SEK 180M (or $18.6M).
See Dignitana trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $18.6M | $18.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Dignitana has market cap of $18.2M and EV of $18.6M.
Dignitana's trades at 2.0x EV/Revenue multiple, and -56.8x EV/EBITDA.
Equity research analysts estimate Dignitana's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dignitana has a P/E ratio of -12.9x.
See valuation multiples for Dignitana and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $18.2M | XXX | $18.2M | XXX | XXX | XXX |
| EV (current) | $18.6M | XXX | $18.6M | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | 477.2x | XXX | -56.8x | XXX | XXX | XXX |
| EV/EBIT | -14.8x | XXX | -9.9x | XXX | XXX | XXX |
| EV/Gross Profit | 2.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | -12.9x | XXX | -9.2x | XXX | XXX | XXX |
| EV/FCF | -29.1x | XXX | -44.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDignitana's last 12 month revenue growth is 24%
Dignitana's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.3M for the same period.
Dignitana's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dignitana's rule of X is 61% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Dignitana and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | 25% | XXX | XXX | XXX |
| EBITDA Margin | 0% | XXX | -4% | XXX | XXX | XXX |
| EBITDA Growth | 4970% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 24% | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 61% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 87% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dignitana acquired XXX companies to date.
Last acquisition by Dignitana was XXXXXXXX, XXXXX XXXXX XXXXXX . Dignitana acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Dignitana founded? | Dignitana was founded in 2007. |
| Where is Dignitana headquartered? | Dignitana is headquartered in Sweden. |
| How many employees does Dignitana have? | As of today, Dignitana has 27 employees. |
| Is Dignitana publicy listed? | Yes, Dignitana is a public company listed on STO. |
| What is the stock symbol of Dignitana? | Dignitana trades under DIGN ticker. |
| When did Dignitana go public? | Dignitana went public in 2009. |
| Who are competitors of Dignitana? | Similar companies to Dignitana include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Dignitana? | Dignitana's current market cap is $18.2M |
| What is the current revenue of Dignitana? | Dignitana's last 12 months revenue is $10.0M. |
| What is the current revenue growth of Dignitana? | Dignitana revenue growth (NTM/LTM) is 24%. |
| What is the current EV/Revenue multiple of Dignitana? | Current revenue multiple of Dignitana is 1.9x. |
| Is Dignitana profitable? | Yes, Dignitana is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dignitana? | Dignitana's last 12 months EBITDA is $39K. |
| What is Dignitana's EBITDA margin? | Dignitana's last 12 months EBITDA margin is 0%. |
| What is the current EV/EBITDA multiple of Dignitana? | Current EBITDA multiple of Dignitana is 477.2x. |
| What is the current FCF of Dignitana? | Dignitana's last 12 months FCF is -$0.6M. |
| What is Dignitana's FCF margin? | Dignitana's last 12 months FCF margin is -6%. |
| What is the current EV/FCF multiple of Dignitana? | Current FCF multiple of Dignitana is -29.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
